World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10024
World Ranking
3983
National Ranking
155

Pilar Barrera publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pilar Barrera sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 122 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pilar Barrera D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pilar Barrera sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pilar Barrera is affiliated with Radboud University Nijmegen Medical Centre in the Netherlands. Their research primarily focuses on medical sciences, with a particular emphasis on hepatology, epidemiology, surgery, oncology, and pathology and forensic medicine.

The scientist's work features multiple topics related to liver diseases, including:

  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Organ Transplantation Techniques and Outcomes
  • Cancer Cells and Metastasis

Frequent publication venues in which Barrera has contributed include:

  • Journal of Hepatology
  • Gastroenterología y Hepatología
  • International Journal of Molecular Sciences
  • Journal of Translational Medicine
  • Nefrología

Barrera has collaborated extensively with several coauthors, notably:

  • Manuel Rodríguez-Perálvarez
  • Manuel de la Mata
  • J.L. Montero
  • Antonio Poyato González
  • Javier Zamora

Some recent papers published by Barrera include:

  • Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2023, International Journal of Molecular Sciences)
  • Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma (2025, Journal of Translational Medicine)
  • Profilaxis y tratamiento de la infección por virus de la hepatitis B en el trasplante hepático. VII Documento de consenso de la Sociedad Española de Trasplante Hepático (2020, Gastroenterología y Hepatología)
  • Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the liver (2020, Revista Española de Enfermedades Digestivas)
  • Current status of hepatitis delta in Andalusia: multicenter study (2023, Journal of Hepatology)

Best Publications

  • A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

    Bruno Sangro;Carlos Gomez-Martin;Manuel de la Mata;Mercedes Iñarrairaegui

  • New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study

    François Cornélis;Sabine Fauré;Maria Martinez;Jean-François Prud’homme

  • Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages

    E R Vossenaar;T R D Radstake;A van der Heijden;M A M van Mansum

  • Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

    Timothy R D J Radstake;Mieke F Roelofs;Yvonne M Jenniskens;Birgitte Oppers-Walgreen

  • IL-32, a proinflammatory cytokine in rheumatoid arthritis.

    Leo A. B. Joosten;Mihai G. Netea;Soo-Hyun Kim;Do-Young Yoon

  • Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis

    Pilar Barrera;Arjen Blom;Peter L. E. M. Van Lent;Louis Van Bloois

  • Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

    Alexandra Zhernakova;Behrooz Z. Alizadeh;Behrooz Z. Alizadeh;Marianna Bevova;Miek A. van Leeuwen

  • Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation

    A A den Broeder;L A B Joosten;Tore Saxne;Dick Heinegård

  • Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis

    C Popa;M G Netea;T R D S Radstake;P L van Riel

  • Circulating soluble tumor necrosis factor receptors, interleukin‐2 receptors, tumor necrosis factor α, and interleukin‐6 levels in rheumatoid arthritis.

    Pilar Barrera;Agnes M. Th. Boerbooms;Elly M. Janssen;Robert W. Sauerwein

  • Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations.

    G.J.D. Hengstman;F.H.J. van den Hoogen;P. Barrera;M.G. Netea

  • Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis

    Calin Popa;Frank H J van den Hoogen;Timothy R D J Radstake;Mihai G Netea

  • Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

    P Barrera;L A B Joosten;A A den Broeder;L B A van de Putte

  • The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome.

    Timothy R. D. J. Radstake;Barbara Franke;Suzanne Hanssen;Mihai G. Netea

  • Common and different genetic background for rheumatoid arthritis and coeliac disease

    Marieke J.H. Coenen;Gosia Trynka;Sandra Heskamp;Barbara Franke

  • Methotrexate-related pulmonary complications in rheumatoid arthritis.

    P. Barrera;R. F. J. M. Laan;P. L. C. M. Van Riel;P. N. R. Dekhuijzen

  • Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.

    Mihai G. Netea;Timothy Radstake;Leo A. Joosten;Jos W. M. van der Meer

  • Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

    Leo A B Joosten;Timothy R D Radstake;Erik Lubberts;Liduine A M van den Bersselaar

  • Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population.

    A Zhernakova;P Eerligh;C Wijmenga;P Barrera

  • Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

    C Popa;L J H van Tits;P Barrera;H L M Lemmers

Frequent Co-Authors

Timothy R D J Radstake
Timothy R D J Radstake Utrecht University
L. B. A. Van De Putte
L. B. A. Van De Putte Radboud University
P.L.C.M. van Riel
P.L.C.M. van Riel Radboud University
Alejandro Balsa
Alejandro Balsa Hospital Universitario La Paz
Barbara Franke
Barbara Franke Radboud University
Paola Migliorini
Paola Migliorini University of Pisa
Mihai G. Netea
Mihai G. Netea Radboud University
Bobby P.C. Koeleman
Bobby P.C. Koeleman Utrecht University
Leo A. B. Joosten
Leo A. B. Joosten Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond Immunology, various online degrees offer flexible options to advance careers in healthcare. Many students explore programs like easy LPN programs to get into. These provide a streamlined path for becoming a Licensed Practical Nurse, a critical role in patient care.

Building on that foundation, easiest nurse practitioner degree programs provide accessible routes to higher qualifications. These programs are designed with flexible schedules and accommodating admission criteria, helping students achieve advanced clinical roles.

For those specializing in mental health, the best online PMHNP programs offer excellent clinical placement opportunities. Quality clinical experience is crucial for Psychiatric Mental Health Nurse Practitioners to gain hands-on skills in diverse settings.

Cost is often a concern, making cheap psych NP programs highly appealing. These affordable options allow students to pursue specialized psychiatric nursing without a heavy financial burden.

Exploring these related pathways can provide valuable career opportunities while complementing a foundation in Immunology.

Best Scientists Citing Pilar Barrera

Recently Published Articles